Under construction – not a live service
Sign in
Taking peopleNo phase

Studying how to choose treatment for spine fractures caused by osteoporosis

Observes people with osteoporosis-related spine fractures to guide treatment decisions.

Plain-language title generated from the registry record
Registry title: The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Key facts

Where
Philadelphia and San Francisco, United StatesSee the 2 sites

Where in United States

  • Thomas Jefferson University HospitalPhiladelphia, United StatesNot yet recruiting
  • University of California San Francisco (USCF) Department of Orthopaedic SurgerySan Francisco, United StatesNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
AO Foundation, AO Spine
Trial code
NCT07027306
Record updated
13 May 2026
Original description
This is an international multicenter prospective observational study. Patients with radiologically confirmed, symptomatic, single- or multilevel contiguous TL (from T1 to L5) fractures as a result of primary osteoporosis will be recruited from participating clinics/hospitals (ie, study sites). Fractures included are insufficiency fractures (confirmed by magnetic resonance imaging [MRI]) and traumatic fractures (low-energy trauma, confirmed by computed tomography [CT] or MRI).Read full original descriptionShow less

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures: An International Multicenter Prospective Study

This is an international multicenter prospective observational study. Patients with radiologically confirmed, symptomatic, single- or multilevel contiguous TL (from T1 to L5) fractures as a result of primary osteoporosis will be recruited from participating clinics/hospitals (ie, study sites). Fractures included are insufficiency fractures (confirmed by magnetic resonance imaging [MRI]) and traumatic fractures (low-energy trauma, confirmed by computed tomography [CT] or MRI).

Inclusion: Postmenopausal women ≥ 50 years old or men > 60 years old; o Menopause refers to amenorrhea for 1 complete year; Radiologically confirmed new diagnosis of symptomatic, single or multilevel TL (from T1 to L5) fractures, ie, the index fracture(s); In case of a multilevel fracture, the fracture must be contiguous; The index fracture is confirmed by MRI as an insufficiency (or fragility) fracture or is confirmed by CT or MRI as traumatic fracture (low-energy trauma); The index fracture(s) is a result of primary osteoporosis. Diagnosis of primary osteoporosis is based on any of the followings in the absence of causes for secondary osteoporosis (such as long-term use of steroids, rheumatoid arthritis, type 1 diabetes mellitus [DM], and other metabolic bone disorders [eg, rickets/osteomalacia, Paget's disease, osteogenesis imperfecta, and primary hyperparathyroidism]) [13-15]:; A T-score ≤ -2.5 in the lumbar spine, femoral neck, total hip, or 1/3 radius; Presence of fragility fracture (either a previous fragility fracture or the index fracture is a fragility fracture). Fragility fractures are fractures due to no or low-energy trauma, eg, slips, trips, or falls from less than double the body height, and heavy lifting; The index osteoporotic TL fracture being classified based on the OF Classification from OF 1 to OF 5:; OF 1: No deformation (vertebral body edema on MRI using short tau inversion recovery [STIR] sequence); OF 2: Deformation of one endplate; OF 3: Deformation of one endplate with distinct posterior wall involvement; OF 4: Deformation of both endplates with/without posterior wall involvement; OF 5: Injuries with anterior or posterior tension band failure; Ability to provide informed consent according to the EC/IRB defined and approved procedures.

Exclusion: Patients with concomitant cervical fractures; Patients with concomitant fracture in the pelvis, upper extremities, and/or lower extremities which could affect the main study outcomes (specifically, patient mobility and pain); Previous instrumented surgery in the affected spine levels; Patients with single-level fracture or contiguous multilevel fracture adjacent to previous instrumented surgery; Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study; Patients showing any signs of spinal infections; Recent history of substance abuse (ie, recreational drugs and alcohol) that would preclude reliable assessments; Patients with spinal tumors; Patients with fractures due to high-energy or high-impact trauma, eg, a fall from double the body height or higher, motor vehicle accident with > 100 km/h in cars with airbags, or motor vehicle accident > 50 km/h without airbags, polytrauma; Patients for whom no FUs are possible; Patients who are mentally impaired and therefore not able to adhere to the study procedures and data collection; Patients who are bedridden before the index fracture.

ClinicalTrials.gov NCT07027306